Computational approaches for the design of novel dopamine D(2) and serotonin 5-HT(2A) receptor dual antagonist towards schizophrenia

利用计算方法设计新型多巴胺D(2)和5-羟色胺5-HT(2A)受体双重拮抗剂治疗精神分裂症

阅读:1

Abstract

Piperidine and piperazine derivatives exhibit a diverse range of biological applications, including antipsychotic activity. In this study, a dataset of molecules containing piperidine, piperazine moieties that possess serotonin 5-HT(2A) and dopamine D(2) inhibitory activity have been chosen for Pharmacophore modeling, Quantitative Structure-Activity (3D-QSAR) Relationship, Molecular docking, and ADME studies. The pharmacophoric hypothesis was found to be AAHPRRR_1 having seven features as one H-bond acceptor (A), one hydrophobic (H), one positive ion acceptor (P), and three aromatic rings (R), with survival score = 6.465 and AUC = 0.92. Based on the best hypothesis, the ZINC-Data base was virtually screened to find out the lead molecules. 3D-QSAR model, including internal and external validation showed comparative molecular field analysis (CoMFA) against 5HT(2A) (q (2) = 0.552, R (2) = 0.889, and r (2) poured. = 0.653 and number of component 5) and comparative molecular similarity indices analysis (CoMSIA) (q (2) = 0.599, R (2) = 0.893, and r (2) pred. = 0.617), for D(2) (CoMFA, q (2) = 0.577, R (2) = 0.863, and r (2) pred. = 0.598) (CoMSIA, q (2) = 0.532, R (2) = 0.82) all results exhibited better productivity and significant statistical reliability of the model. The docking study was carried out on the crystal structure of 5-HT(2A) having PDB ID; 6A93 and D(2) receptor having PDB ID; 6CM4. The screened compound ZINC74289318 possess a higher docking score - 10.744 and - 11.388 than co-crystallized ligand docking score - 8.840 and - 10.06 against 5-HT(2A) and D(2) receptor respectively. Further, ZINC74289318 was screened for all drug-likeness parameters and no showed violation of the Lipinski rule of five. Also, it was found to possess good bioavailability of 0.55 with synthetic accessibility of 4.42 which is greater than risperidone.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。